or
forgot password
  • cancer clinical trials in ann arbor, MI

  • Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Recurrent Childhood Medulloblastoma, Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
    Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Malignant Salivary Gland Tumors That Have Been Removed By Surgery
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Head and Neck Cancer
    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Adult Rhabdomyosarcoma, Alveolar Childhood Rhabdomyosarcoma, Mixed Childhood Rhabdomyosarcoma, Pleomorphic Childhood Rhabdomyosarcoma, Previously Treated Childhood Rhabdomyosarcoma, Recurrent Adult Soft Tissue Sarcoma, Recurrent Childhood Rhabdomyosarcoma
    Refining Information Technology Support for Genetics in Medicine
    University of Michigan Cardiovascular Center
    Ann Arbor, Michigan 48109
    Hypertrophic Cardiomyopathy, Hearing Loss, Cancer
    Everolimus and Octreotide With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed By Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Gastrinoma, Glucagonoma, Insulinoma, Pancreatic Alpha Cell Adenoma, Pancreatic Alpha Cell Carcinoma, Pancreatic Beta Islet Cell Adenoma, Pancreatic Beta Islet Cell Carcinoma, Pancreatic Delta Cell Adenoma, Pancreatic Delta Cell Carcinoma, Pancreatic G-cell Adenoma, Pancreatic G-cell Carcinoma, Pancreatic Polypeptide Tumor, Recurrent Islet Cell Carcinoma, Recurrent Pancreatic Cancer, Somatostatinoma, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer
    Entinostat and Anastrozole in Treating Postmenopausal Women With Triple-Negative Breast Cancer That Can Be Removed by Surgery
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer, Stage I Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Triple-negative Breast Cancer
    Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Spinal Cord Neoplasm, Untreated Childhood Brain Stem Glioma, Untreated Childhood Cerebral Astrocytoma
    A Trial of LEE011 in Patients With Advanced Solid Tumors or Lymphoma
    University of Michigan Comprehensive Cancer Center SC
    Ann Arbor, Michigan 48109-0944
    Advanced Solid Tumor, Lymphomas
    Diet in Altering Disease Progression in Patients With Prostate Cancer on Active Surveillance
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors
    C S Mott Children's Hospital
    Ann Arbor, Michigan 48109
    Unspecified Childhood Solid Tumor, Protocol Specific
    Randomized Study of ON 01910.Na in Refractory Myelodysplastic Syndrome Patients With Excess Blasts
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Myelodysplastic Syndromes, MDS, RAEB, Chronic Myelomonocytic Leukemia
    Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Breast Cancer
    A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Multiple Myeloma, Plasma Cell Leukemia
    Radiation With Cetuximab in Head and Neck Squamous Cell Carcinoma Who Do Not Qualify For Chemotherapy
    The University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109
    Squamous Cell Carcinoma of the Larynx, Hypopharynx, Oropharynx, or Oral Cavity., The Patients Will be Limited to Age 70 and Older,, OR w/ Co-morbidities Precluding Treatment With Chemotherapy
    Bicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate Cancer
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer, Stage IIB Prostate Cancer, Stage III Prostate Cancer
    Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Ann Arbor, Michigan 48106
    Adenocarcinoma of the Gastroesophageal Junction, Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer
    Saracatinib in Treating Patients With Prostate Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer, Stage IV Prostate Cancer
    Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
    Michigan Center for Oral Health Research
    Ann Arbor, Michigan 48106
    Breast Cancer, Xerostomia
    Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Brain and Central Nervous System Tumors, Lymphoma, Lymphoproliferative Disorder, Small Intestine Cancer, Unspecified Childhood Solid Tumor, Protocol Specific
    Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III or Stage IV Melanoma That Has Been Removed by Surgery
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    University of Michigan University Hospital
    Recurrent Melanoma, Stage IIIB Melanoma, Stage IIIC Melanoma, Stage IV Melanoma
    Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IA Breast Cancer, Stage IB Breast Cancer, Stage II Breast Cancer, Stage IIIA Breast Cancer, Stage IIIC Breast Cancer
    A Dose Escalation Study of OMP-59R5 in Subjects With Solid Tumors
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Solid Tumors
    Selumetinib in Treating Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Recurrent Adult Diffuse Large Cell Lymphoma
    Exercise and Stress Management Post Autologous and Allogeneic Transplant
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Physiological Stress
    Lapatinib Ditosylate and Akt Inhibitor MK2206 in Treating Women With Metastatic Breast Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Estrogen Receptor-negative Breast Cancer, Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer, Progesterone Receptor-negative Breast Cancer, Progesterone Receptor-positive Breast Cancer, Recurrent Breast Cancer, Stage IV Breast Cancer
    Acupressure for Persistent Cancer Related Fatigue
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Chronic Fatigue, Breast Cancer, Sleepiness
    Ofatumumab and Bendamustine Hydrochloride With or Without Bortezomib in Treating Patients With Untreated Follicular Non-Hodgkin Lymphoma
    Saint Joseph Mercy Hospital
    Ann Arbor, Michigan 48106
    Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma
    Study of BMN 673, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors
    University of Michigan Health System
    Ann Arbor, Michigan
    Advanced or Recurrent Solid Tumors, Breast Neoplasms, Ovarian Cancer, Epithelial, Ewing Sarcoma, Small Cell Lung Carcinoma, Prostate Cancer, Pancreas Cancer
    Hypofractionated Stereotactic Body Radiation Therapy (SBRT)
    University of Michigan Cancer Center
    Ann Arbor, Michigan 48109
    Prostate Cancer
    A Study of MDV3100 Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Prostatic Neoplasms
    Tesetaxel in Chemotherapy-naive Patients With Progressive, Castration-resistant Prostate Cancer
    University of Michigan Health System
    Ann Arbor, Michigan
    Prostate Cancer
    Radiation Therapy With Cisplatin or Cetuximab in Treating Patients With Oropharyngeal Cancer
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    Head and Neck Cancer, Precancerous Condition
    Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Bacterial Infection, Mucositis, Neutropenia
    Bevacizumab With or Without Fosbretabulin Tromethamine in Patients With Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
    University of Michigan University Hospital
    Ann Arbor, Michigan 48109
    Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    C.S. Mott Children's Hospital at University of Michigan Medical Center
    Ann Arbor, Michigan 48109-0286
    Fungal Infection, Leukemia, Neutropenia
    Abraxane With or Without Tigatuzumab in Patients With Metastatic, Triple Negative Breast Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Breast Cancer, Triple Negative Breast Cancer, Stage IV Breast Cancer, Metastatic Breast Cancer
    S1014 Abiraterone Acetate in Treating Patients With Prostate Cancer Who Have Undergone Initial Hormone Therapy
    University of Michigan Comprehensive Cancer Center

    Trial Locations
    University of Michigan Comprehensive Cancer Center
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Prostate Cancer
    Effectiveness of Open and Robotic Prostatectomy
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Prostate Cancer
    PET Scan Imaging in Assessing Response in Patients With Esophageal Cancer Receiving Combination Chemotherapy
    Saint Joseph Mercy Cancer Center
    Ann Arbor, Michigan 48106-0995
    Adenocarcinoma of the Gastroesophageal Junction, Esophageal Cancer
    Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure
    University of Michigan
    Ann Arbor, Michigan 48109-0624
    Acute Lung Injury, Acute Respiratory Distress Syndrome, Respiratory Failure
    A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Solid Tumors
    Patients Treated for SCID (1968-2010)
    University of Michigan Health System
    Ann Arbor, Michigan
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
    Irinotecan Plus E7820 Versus FOLFIRI in Second-Line Therapy in Patients With Locally Advanced or Metastatic Colon or Rectal Cancer
    University of Michigan Comprehensive Cancer Center
    Ann Arbor, Michigan 48109-0752
    Colon Cancer and Rectal Cancer
    S0820, Adenoma and Second Primary Prevention Trial
    Saint Joseph Mercy Hospital

    Trial Locations
    Saint Joseph Mercy Hospital
    Michigan Cancer Research Consortium Community Clinical Oncology Program
    Colorectal Neoplasms
    BMS-936558 (MDX-1106) In Subjects With Advanced/Metastatic Clear-Cell Renal Cell Carcinoma (RCC)
    University of Michigan Medical Center
    Ann Arbor, Michigan 48104-0914
    Renal Cell Carcinoma
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    CCOP - Michigan Cancer Research Consortium

    Trial Locations
    CCOP - Michigan Cancer Research Consortium
    Saint Joseph Mercy Cancer Center
    Lymphoma